Skip to content

The efficacy of vitamin D administration in non-alchoholic fatty liver disease(NAFLD)

Evaluation of vitamin D administration in non-alchoholic fatty liver disease(NAFLD)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015102624725N1
Enrollment
40
Registered
2016-01-03
Start date
2014-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic fatty liver disease (NAFLD). Nonalcoholic fatty liver disease (NAFLD

Interventions

Intervention 1: Intervention:administration of vitamin D pearl and life style modification. Intervention 2: Control: lifestyle modification.
Treatment - Drugs
Lifestyle
Intervention:administration of vitamin D pearl and life style modification
Control: lifestyle modification

Sponsors

Vice Chancellor for Research Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria: ALT rising equals or more than 2times of normal level; probable diagnosis of Nonalcoholic Steatohepatitis and rule out of other hepatic-enzymes rising causes such as viral and autoimmune hepatitis; age more than 18 years; serum vitamin D level less than 30 nanogram per mililiter Exclusion Criteria: hepatic cirrhosis; pregnancy or breast-feeding; alcohol use ; substance abuse;vitamin D administration in 6 months ago, weight loss more than 5% in 1 year ago; newly-diagnosed diabetes (in the recent 1 year) which needs treatment: antioverweight medication ; hypercalcemia; chronic renal disease; life-threatening cardiopulmonary diseases ; hyperlipidemia which needs medication; medications which affect on hepatic enzymes

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The level of aminotransferases. Timepoint: 3th and 6th month. Method of measurement: biochemical.;Fibroscan and BMI. Timepoint: 3th and 6th month for BMI and 6th month for fibroscan. Method of measurement: fibroscan and anthropometric measurement( kg/m2).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTarang Taghvaei

Mazandaran University of Medical Sciences

Tarang_taghvaei@yahoo.com+98 11 3335 0670

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026